The effect of drinking behaviour on quality of life in patients with established alcoholic liver disease.

被引：0
|
作者：
Warren, M
Godfrey, C
James, O
机构：
[1] Univ Newcastle Upon Tyne, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[2] Univ York, York YO1 5DD, N Yorkshire, England
来源：
HEPATOLOGY | 2002年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1469
引用
收藏
页码：530A / 530A
页数：1
相关论文
共 50 条
  • [41] Long-Term Outcome of Living Donor Liver Transplantation for Patients With Alcoholic Liver Disease.
    Hwang, Shin
    Ahn, Chul-Soo
    Moon, Deok-Bog
    Ha, Tae-Yong
    Song, Gi-Won
    Jung, Dong-Hwan
    Park, Gil-Chun
    Lee, Sung-Gyu
    LIVER TRANSPLANTATION, 2014, 20 : S325 - S326
  • [42] Sarcopenia is associated with advanced liver fibrosis in patients with non-alcoholic fatty liver disease.
    Kang, Min Kyu
    Park, Jung Gil
    Kim, Min Cheol
    Lee, Heon Ju
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 421 - 421
  • [43] Sarcopenia Is Associated with Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.
    Kang, Min Kyu
    Park, Jung Gil
    Kim, Min Cheol
    Park, Soo Young
    Lee, Heon Ju
    Tak, Won Young
    Kweon, Young-Oh
    Jang, Se Young
    Lee, Yu Rim
    HEPATOLOGY, 2018, 68 : 1306A - 1306A
  • [44] Effect of switching to budesonide on the quality of life of patients with steroid dependent Crohn's disease.
    Cortot, A
    Colombel, JF
    Rutgeerts, P
    Lauritsen, K
    Malchow, H
    Hamling, J
    Winter, T
    Van Gossum, A
    Persson, T
    Pettersson, E
    GASTROENTEROLOGY, 2001, 120 (05) : A748 - A748
  • [45] Lipidic last breath of life in patients with alcoholic liver disease
    Raszeja-Wyszomirska, Joanna
    Safranow, Krzysztof
    Milkiewicz, Malgorzata
    Milkiewicz, Piotr
    Szynkowska, Agnieszka
    Stachowska, Ewa
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2012, 99 (1-2) : 51 - 56
  • [46] QUALITY-OF-LIFE FOLLOWING LIVER-TRANSPLANTATION FOR ALCOHOLIC LIVER-DISEASE
    REECK, UH
    EGERER, G
    ARNOLD, JC
    DATSIS, K
    THEILMANN, L
    OTTO, G
    KOMMERELL, B
    GASTROENTEROLOGY, 1993, 104 (04) : A977 - A977
  • [47] Reversibility of mitochondrial DNA mutation in alcoholic liver disease.
    Tsutsumi, M
    Tsuchishima, M
    Shiroeda, K
    Ueshima, Y
    Kawahara, H
    Takase, S
    HEPATOLOGY, 1998, 28 (04) : 669A - 669A
  • [48] Kupffer cells as a therapeutic target of alcoholic liver disease.
    Takei, Y
    Enomoto, N
    Ikejima, K
    Yamashina, S
    Sato, N
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2004, 28 (08) : 80A - 80A
  • [49] Histomorphometric assessment of fibrosis in advanced alcoholic liver disease.
    de Ridder, RJ
    Arends, JW
    Stockbrügger, RW
    Adang, RP
    GASTROENTEROLOGY, 1998, 114 (04) : A1233 - A1233
  • [50] Studies on the reversibility of hepatic fibrosis in alcoholic liver disease.
    Tsutsumi, M
    Urashima, S
    Ueshima, Y
    Kawahara, H
    Takase, S
    HEPATOLOGY, 1996, 24 (04) : 1860 - 1860
12345